Where Will Oncology Pharma Inc (ONPH) Stock Go Next After It Has Risen 69.97% in a Week?

The market has been high on Oncology Pharma Inc (ONPH) stock recently. ONPH gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Oncology Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ONPH!

See Full ONPH Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ONPH Stock Today?

Oncology Pharma Inc (ONPH) stock is trading at $5.15 as of 9:47 AM on Tuesday, Dec 21, a rise of $1.01, or 24.4% from the previous closing price of $4.14. The stock has traded between $4.15 and $5.25 so far today. Volume today is low. So far 59,667 shares have traded compared to average volume of 218,237 shares.

More About Oncology Pharma Inc

Oncology Pharma Inc is an oncology company. It is engaged in the development, manufacturing, and commercialization of therapeutics. Its NanoSmart's platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. The company has developed a novel drug delivery vehicle that targets many types of cancer. Click Here to get the full Stock Report for Oncology Pharma Inc stock.